Clinical TrialsSearch results
Number of results: 482
Recruiting
- Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents with Osteogenesis Imperfecta
- Osteogenesis Imperfecta
- Asato Keita
- 2024-02-28
Recruiting
- Comparison of the accuracy for cup orientation in total hip arthroplasty
- Osteoarthrosis, osteonecrosis of the femoral head, rheumatoid arthritis, femoral neck fracture
- Tetsunaga Tomonori
- 2022-03-10
Recruiting
- HFVI Study
- Osteoarthritis
- Morimatsu Hiroshi
- 2024-05-17
Recruiting
- Exploratory study to investigate the efficacy of a novel mucosal protection method for oral mucositis
- Oral mucositis
- Omori Kazuhiro
- 2023-01-19
Recruiting
- Application of Nudge Theory to Changes in Oral Health Behavior in the Over-65s
- none
- Ekuni Daisuke
- 2024-01-19
Recruiting
- Prospective study of pemafIbrate in patients with NAFLD
- Nonalcoholic fatty liver disease
- Otsuka Motoyuki
- 2023-11-02
Other
- A phase II study of Iressa and vinorelbine/gemcitabine in chemo-naive elderly patients with advanced non-small-cell lung cancer screened for EGFR mutation status.
- Non-small-cell lung cancer
- IVAN Investigators
- 2006-06-23
Other
- Phase II study of cisplatin, docetaxel, and irinotecan, followed by gefitinib, gemcitabine and vinorelbine for patients with non-small-cell lung cancer harboring active EGFR gene mutations (OLCSG0704)
- non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2009-08-01
Other
- Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0803/WJOG4307L)
- non-small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2008-10-10
Recruiting
- A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Non-Small Cell Lung Cancer (NSCLC)
- Nakatani Iwami
- 2023-12-06